PTPRC and melanoma: To interpret the impact of miR-155 deficiency on the TIL landscape, we submitted to ProjecTILs the data from Ekiz et al.34, which consist of total immune (CD45+) single cells from untreated B16 melanoma tumors growing in miR-155 T cell conditional knock-out (KO) mice, as well as in wild type (WT) mice.